DOI:
10.1055/s-00046370
Global Medical Genetics
LinksClose Window
References
Robichaux JP, Elamin YY, Tan Z. et al.
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
Nat Med 2018;
24 (05) 638-646
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.